| Cover | Nov. 13, 2024 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Document Period End Date | Nov. 13, 2024 |
| Registrant Name | QUINCE THERAPEUTICS, INC. |
| Entity Incorporation, State or Country Code | DE |
| Entity File Number | 001-38890 |
| Entity Tax Identification Number | 90-1024039 |
| Entity Address, Address Line One | 601 Gateway Boulevard |
| Entity Address, Postal Zip Code | 94080 |
| Entity Address, Address Line Two | Suite 1250 |
| Entity Address, City or Town | South San Francisco |
| Entity Address, State or Province | CA |
| Local Phone Number | 910-5717 |
| City Area Code | 415 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, par value $0.001 per share |
| Trading Symbol | QNCX |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | false |
| Central Index Key | 0001662774 |
| Amendment Flag | false |
